AGITATION,PSYCHOMOTOR
Clinical trials for AGITATION,PSYCHOMOTOR explained in plain language.
Never miss a new study
Get alerted when new AGITATION,PSYCHOMOTOR trials appear
Sign up with your email to follow new studies for AGITATION,PSYCHOMOTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New At-Home calming treatment tested for mental health crises
Symptom relief CompletedThis study tested a medication called BXCL501 to see if it could safely and effectively calm episodes of agitation when used at home by adults with schizophrenia or bipolar disorder. In the second part of the trial, 452 participants used the medication as needed over 12 weeks at …
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: PHASE3 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
Agitation drug put to the test: does stopping cause problems?
Symptom relief CompletedThis study looked at what happens when people with schizophrenia or bipolar disorder stop taking a short-term medication for agitation. Researchers gave 29 adults the drug Igalmi as needed for 7 days to calm agitation episodes, then monitored them for 3 days after stopping. The m…
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: PHASE4 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC
-
New Alzheimer's agitation treatment shows promise in major trial
Symptom relief CompletedThis study tested whether AXS-05 is safe and effective for reducing agitation in people with Alzheimer's disease over a long period. 456 participants who had already shown benefit from AXS-05 in previous studies were either kept on the medication or switched to placebo to see if …
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Mar 16, 2026 15:23 UTC